Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide

International Journal of Cancer, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2qAkFP8
via IFTTT